Cresco Labs Inc. (CL.CN)
CAD 0.84
(-2.33%)
CAD 0.84
(-2.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -14.35 Million USD | 9.69% |
| 2022 | -10.66 Million USD | -7.11% |
| 2021 | -159.62 Million USD | 35.19% |
| 2020 | 5.22 Million USD | 655.35% |
| 2019 | -17.7 Million USD | -271.71% |
| 2018 | 9.66 Million USD | 23666.36% |
| 2017 | -43.75 Thousand USD | -30.17% |
| 2016 | -33.61 Thousand USD | -150.96% |
| 2015 | 65.95 Thousand USD | 229.09% |
| 2014 | -51.09 Thousand USD | 66.92% |
| 2013 | -154.43 Thousand USD | 50.22% |
| 2012 | -310.26 Thousand USD | 8.56% |
| 2011 | -339.32 Thousand USD | -118.82% |
| 2010 | 1.8 Million USD | 544.83% |
| 2009 | -405.23 Thousand USD | 31.82% |
| 2008 | -594.33 Thousand USD | 11.77% |
| 2007 | -673.65 Thousand USD | -673.61% |
| 2006 | 117.44 Thousand USD | 107.55% |
| 2005 | -1.55 Million USD | -252.44% |
| 2004 | -441.25 Thousand USD | -143.68% |
| 2003 | -181.07 Thousand USD | -38.32% |
| 2002 | -130.91 Thousand USD | -314.59% |
| 2001 | -31.57 Thousand USD | 89.62% |
| 2000 | -304.24 Thousand USD | -42.28% |
| 1999 | -213.83 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 48.06 Million USD | -2.68% |
| 2024 Q2 | -9.94 Million USD | -120.68% |
| 2023 Q3 | 28 Million USD | 141.93% |
| 2023 Q4 | 49.31 Million USD | 76.08% |
| 2023 Q2 | 11.57 Million USD | 31.28% |
| 2023 FY | - USD | 9.69% |
| 2023 Q1 | 8.81 Million USD | -36.96% |
| 2022 Q2 | 46.39 Million USD | 42.27% |
| 2022 Q4 | 13.98 Million USD | -55.8% |
| 2022 FY | - USD | -7.11% |
| 2022 Q1 | 32.61 Million USD | -15.65% |
| 2022 Q3 | 31.64 Million USD | -31.79% |
| 2021 Q3 | 38.79 Million USD | 33.1% |
| 2021 Q4 | 38.66 Million USD | -0.35% |
| 2021 FY | - USD | 35.19% |
| 2021 Q1 | 35.63 Million USD | 4.43% |
| 2021 Q2 | 29.14 Million USD | -18.21% |
| 2020 Q4 | 34.12 Million USD | -21.29% |
| 2020 FY | - USD | 655.35% |
| 2020 Q2 | 30.01 Million USD | 494.29% |
| 2020 Q3 | 43.35 Million USD | 44.44% |
| 2020 Q1 | -7.61 Million USD | 61.28% |
| 2019 Q3 | -914 Thousand USD | -114.15% |
| 2019 FY | - USD | -271.71% |
| 2019 Q2 | 6.46 Million USD | 279.94% |
| 2019 Q4 | -19.66 Million USD | -2051.2% |
| 2019 Q1 | -3.59 Million USD | -271.36% |
| 2018 Q3 | -62.24 Thousand USD | -194.4% |
| 2018 Q1 | -11.85 Thousand USD | 44.87% |
| 2018 FY | - USD | 23666.36% |
| 2018 Q4 | 2.09 Million USD | 3465.48% |
| 2018 Q2 | 65.94 Thousand USD | 656.2% |
| 2017 FY | - USD | -30.17% |
| 2017 Q3 | -5456.35 USD | 43.38% |
| 2017 Q2 | -9636.94 USD | -38.02% |
| 2017 Q4 | -21.5 Thousand USD | -294.17% |
| 2017 Q1 | -6982.42 USD | 55.78% |
| 2016 Q2 | -10.55 Thousand USD | -37.53% |
| 2016 Q3 | -363.01 USD | 96.56% |
| 2016 Q4 | -15.78 Thousand USD | -4249.7% |
| 2016 FY | - USD | -150.96% |
| 2016 Q1 | -7675.76 USD | 44.61% |
| 2015 Q4 | -13.85 Thousand USD | -47.65% |
| 2015 FY | - USD | 229.09% |
| 2015 Q3 | -9385.09 USD | -108.75% |
| 2015 Q2 | 107.26 Thousand USD | 1132.85% |
| 2015 Q1 | -10.38 Thousand USD | 12.7% |
| 2014 Q3 | -20.17 Thousand USD | -22.55% |
| 2014 Q1 | -9190.31 USD | 88.62% |
| 2014 FY | - USD | 66.92% |
| 2014 Q4 | -11.89 Thousand USD | 41.04% |
| 2014 Q2 | -16.46 Thousand USD | -79.14% |
| 2013 Q3 | -49.89 Thousand USD | -87.9% |
| 2013 Q2 | -26.55 Thousand USD | -49.26% |
| 2013 FY | - USD | 50.22% |
| 2013 Q1 | -17.79 Thousand USD | 77.35% |
| 2013 Q4 | -80.73 Thousand USD | -61.79% |
| 2012 FY | - USD | 8.56% |
| 2012 Q3 | -71.39 Thousand USD | -43.15% |
| 2012 Q2 | -49.87 Thousand USD | 56.31% |
| 2012 Q1 | -114.15 Thousand USD | -209.45% |
| 2012 Q4 | -78.55 Thousand USD | -10.04% |
| 2011 Q2 | -333.48 Thousand USD | -486.89% |
| 2011 Q1 | -56.82 Thousand USD | 84.56% |
| 2011 Q3 | -62.72 Thousand USD | 81.19% |
| 2011 Q4 | 104.29 Thousand USD | 266.26% |
| 2011 FY | - USD | -118.82% |
| 2010 Q3 | 10.08 Thousand USD | 111.35% |
| 2010 Q4 | -368.09 Thousand USD | -3748.84% |
| 2010 FY | - USD | 544.83% |
| 2010 Q2 | -88.87 Thousand USD | -22.79% |
| 2010 Q1 | -72.37 Thousand USD | 71.39% |
| 2009 Q3 | -9948.17 USD | -42.06% |
| 2009 Q2 | -7002.77 USD | 87.63% |
| 2009 Q1 | -56.62 Thousand USD | 96.77% |
| 2009 FY | - USD | 31.82% |
| 2009 Q4 | -252.94 Thousand USD | -2442.66% |
| 2008 FY | - USD | 11.77% |
| 2008 Q4 | -1.75 Million USD | -2710.49% |
| 2008 Q2 | -66 Thousand USD | 67.24% |
| 2008 Q1 | -201.47 Thousand USD | -1549.94% |
| 2008 Q3 | -62.33 Thousand USD | 5.56% |
| 2007 FY | - USD | -673.61% |
| 2007 Q4 | -12.21 Thousand USD | 86.69% |
| 2007 Q3 | -91.72 Thousand USD | 79.28% |
| 2007 Q2 | -442.65 Thousand USD | -505.14% |
| 2007 Q1 | -73.14 Thousand USD | -118.21% |
| 2006 Q3 | 11.08 Thousand USD | 106.91% |
| 2006 Q4 | 401.59 Thousand USD | 3522.52% |
| 2006 Q2 | -160.44 Thousand USD | -19.41% |
| 2006 FY | - USD | 107.55% |
| 2006 Q1 | -134.36 Thousand USD | -1115.46% |
| 2005 Q3 | -1.27 Million USD | -1661.59% |
| 2005 Q4 | -11.05 Thousand USD | 99.13% |
| 2005 Q2 | -72.17 Thousand USD | 61.08% |
| 2005 Q1 | -185.46 Thousand USD | 1.54% |
| 2005 FY | - USD | -252.44% |
| 2004 FY | - USD | -143.68% |
| 2004 Q2 | -33.5 Thousand USD | 66.97% |
| 2004 Q4 | -188.37 Thousand USD | -84.7% |
| 2004 Q1 | -101.43 Thousand USD | -258.89% |
| 2004 Q3 | -101.98 Thousand USD | -204.39% |
| 2003 FY | - USD | -38.32% |
| 2003 Q1 | -26.15 Thousand USD | 52.67% |
| 2003 Q2 | -21.82 Thousand USD | 16.55% |
| 2003 Q3 | -164.4 Thousand USD | -653.26% |
| 2003 Q4 | -28.26 Thousand USD | 82.81% |
| 2002 Q1 | -19.52 Thousand USD | 0.0% |
| 2002 FY | - USD | -314.59% |
| 2002 Q4 | -55.26 Thousand USD | -127.14% |
| 2002 Q3 | -24.33 Thousand USD | 22.03% |
| 2002 Q2 | -31.2 Thousand USD | -59.83% |
| 2001 FY | - USD | 89.62% |
| 2000 FY | - USD | -42.28% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | -136.347% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -614.004% |
| Blueberries Medical Corp. | -1.22 Million CAD | -1074.916% |
| The BC Bud Corporation | -1.19 Million CAD | -1100.237% |
| BioNxt Solutions Inc. | -6.48 Million CAD | -121.37% |
| CordovaCann Corp. | -1.6 Million CAD | -795.722% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | -447.18% |
| Captor Capital Corp. | 2.42 Million CAD | 692.895% |
| City View Green Holdings Inc. | -2.01 Million CAD | -612.598% |
| 1CM Inc. | 1.31 Million CAD | 1192.86% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -57799.407% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -550.02% |
| IM Cannabis Corp. | -2.79 Million CAD | -414.516% |
| Lobe Sciences Ltd. | -4.4 Million CAD | -226.08% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -3559.973% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -349.577% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 1357.445% |
| Ovation Science Inc. | -778.83 Thousand CAD | -1743.145% |
| Pharmadrug Inc. | -1.33 Million CAD | -975.27% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | -137.035% |
| RAMM Pharma Corp. | -6.3 Million CAD | -127.782% |
| RIV Capital Inc. | -20.28 Million CAD | 29.217% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | -156.568% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 81.499% |
| SLANG Worldwide Inc. | -2.95 Million CAD | -386.492% |
| 1933 Industries Inc. | -10.03 Million CAD | -43.078% |
| Red Light Holland Corp. | -5.25 Million CAD | -173.124% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -1769.158% |
| Xebra Brands Ltd. | -1.49 Million CAD | -860.203% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -917.173% |